Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
Open | $2.450 |
Close | - |
Volume / Avg. | 9.134K / 77.412K |
Day Range | 2.450 - 2.580 |
52 Wk Range | 2.160 - 4.650 |
Market Cap | $302.737M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 2.49% |
Days to Cover | 18.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 147.93% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $2.42 last updated April 22, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.